Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Aubreyon Apr 05, 2015 10:02am

70 Views

Post# 23598204

RE:RE:RE:RE:Prostate cancer, their next cancer indication ...

Vestor, that's a very good point about all of those other applications. The fact that Rutherrin responds to red and infrared light allows for deeper penetration. Thus a greater distance from a light source ...opens many exciting possibilities. Many doors will swing open, that's why I'm invested there. As Dr Lilge put it at the AGM," It's the versatility of the PDCs that gives me the most confidence"

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages